Factors that influence patient response to requests to change to a unified restrictive formulary: A prospective study

Journal of General Internal Medicine

Volumn 19, Issue 12, 2004, Pages 1212-1219

  Smetana, Gerald W ^a,b   Davis, Roger B ^a   Phillips, Russell S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Drug costs; Formulary; Managed care; Patient preferences

Indexed keywords

ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANXIOLYTIC AGENT; DERMATOLOGICAL AGENT; GASTROINTESTINAL AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICARE; NURSE; PHARMACY; PHYSICIAN; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; QUESTIONNAIRE; REIMBURSEMENT;

ADULT; AGE FACTORS; COHORT STUDIES; COSTS AND COST ANALYSIS; FEMALE; FORMULARIES; HUMANS; MALE; MANAGED CARE PROGRAMS; MULTIVARIATE ANALYSIS; PATIENTS; PHARMACEUTICAL PREPARATIONS; PHYSICIAN-PATIENT RELATIONS; PROSPECTIVE STUDIES; QUESTIONNAIRES; TELEPHONE; UNITED STATES;

EID: 11144256525     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2004.30362.x     Document Type: Article

References (12)

1. Center for Medicare and Medicaid Services National Health Statistics Group, Office of the Actuary. National health expenditures; 2000. Available at: http://www.hcfa.gov/stats/nhe-oact/. Accessed March 15, 2003.
2. National Institute for Health Care Management Research and Educational Foundation. Prescription drug expenditures in 2001: another year of escalating costs. Available at: http://www.nihcm.org. Accessed May 31, 2002.
3. Kao AC, Green DC, Zaslavsky AM, Koplan JP, Cleary PD. The relationship between method of physician payment and patient trust. JAMA. 1998;280:1708-14.
4. Mehta C, Patel N. FEXACT: a Fortran subroutine for Fisher's exact test on unordered r × c contingency tables. TOMS. 1986;12:154-61.
5. Schachtner JM, Guharoy R, Medicis JJ, Newman N, Speizer R. Prevalence and cost savings of therapeutic interchange among U.S. hospitals. Am J Health Syst Pharm. 2002;59:529-33.
6. Chiefari DM. Effect of a highly restrictive formulary on the average prescription cost at a community health center. Am J Health Syst Pharm. 2000;57:846-7.
7. Motheral BR, Henderson R. The effect of a closed formulary on prescription drug use and costs. Inquiry. 1999;36:481-91.
8. Hazlet TK, Hu TW. Association between formulary strategies and hospital drug expenditures. Am J Hosp Pharm. 1992;49:2207-10.
9. Kleinman L, McIntosh E, Ryan M, et al. Willingness to pay for complete symptom relief of gastroesophageal reflux disease. Arch Intern Med. 2002;162:1361-6.
10. Joyce GF, Escarce J, Solomon MD, Goldman DP. Employer drug benefit plans and spending on prescription drugs. JAMA. 2002;288:1733-9.
11. Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB. Outcomes of reference pricing for angiotensin converting enzyme inhibitors. N Engl J Med. 2002;346:822-9.
12. Hensley PL, Nurnberg G. Formulary restriction of selective serotonin reuptake inhibitors for depression. Potential pitfalls. Pharmacoeconomics. 2001;19:973-82.